Table 3.
Results from the linear regression models examining the relationship of metabolites measured at the 12 days assessment and symptoms (cognitive and somatic) measured at the 6 month assessment.
| HBI cognitive symptoms | HBI somatic symptoms | |||
|---|---|---|---|---|
| B (SE) = | p = | B (SE) = | p = | |
| tNAA | − 0.547 (0.75) | 0.465 | 0.334 (0.37) | 0.368 |
| tCr | 0.912 (1.09) | 0.405 | 0.158 (0.55) | 0.772 |
| tCho | − 1.696 (2.14) | 0.428 | − 1.338 (1.06) | 0.207 |
| Glx | − 0.414 (0.24) | 0.08 | − 0.23 (0.12) | 0.051 |
| mI | − 0.227 (0.78) | 0.771 | 0.861 (0.38) | 0.026 |
| Age | − 0.464 (0.19) | 0.013 | 0.143 (0.09) | 0.119 |
| Sex | 0.479 (0.9) | 0.594 | − 0.822 (0.44) | 0.065 |
| Site | − 0.074 (0.31) | 0.815 | 0.081 (0.16) | 0.602 |
| Vendor | − 5.385 (2.17) | 0.014 | 0.758 (1.08) | 0.483 |
The model controls for age, sex, site, and vendor. Significant values are in bold.